Immune Pharma (IMNP) Misses Q1 EPS by 2c

Immune Pharma (NASDAQ: IMNP) reported Q1 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Immune Pharma (IMNP) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
• FGI Industries Ltd (FGI) Tops Q2 EPS by 59c